In hospitalized COVID-19 patients, azvudine shows lower all-cause mortality and fewer adverse events than Paxlovid, with added antitumor effects observed.
X-trodes’ Smart Skin Earns FDA Clearance for Home-Based Electrophysiological Monitoring
What You Should Know: – X-trodes, a pioneer in wireless monitoring solutions, has achieved a major milestone with the U.S. Food and Drug Administration (FDA)
February 21, 2024